Upstream Bio (UPB) Other financing activities (2024 - 2026)

Upstream Bio's Other financing activities history runs 3 years deep, the most recent figure standing at $598000.0 for Q1 2026.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $598000.0 in Q1 2026; TTM through Mar 2026 was $794000.0, a 99.71% decrease from a year earlier, with the FY2025 full-year figure at $196000.0, down 99.93% from the prior year.
• Other financing activities grew to $598000.0 in Q1 2026 per UPB's latest filing, from -$1.2 million in the prior quarter.
• Across five years, Other financing activities topped out at $272.6 million in Q4 2024 and bottomed at -$1.2 million in Q4 2025.
• The 3-year median for Other financing activities is $349000.0 (2024), against an average of $34.2 million.
• Biggest YoY gain for Other financing activities was 3900.0% in 2025; the steepest drop was 100.43% in 2025.
• Year by year, Other financing activities stood at $272.6 million in 2024, then plunged by 100.43% to -$1.2 million in 2025, then surged by 150.85% to $598000.0 in 2026.
• Per Business Quant, the three latest UPB Other financing activities figures stand at $598000.0 (Q1 2026), -$1.2 million (Q4 2025), and $760000.0 (Q3 2025).